Momenta Pharmaceuticals, Inc. (MNTA)

[biopearl]

Mouton thanks for clarification re SG brief relevance to both companies. It would seem that should the case be successfully agued in DC that some liability might fall to both re settlement and punitive damages. My question is this and I am doing this from memory. Did TEVAs product actually come to market? Even if it did it would it have had much less impact on MNTAs income than the avalanche caused by the entry of Ampha/Watson. As Dew has pointed out a potential settlement, assuming the case goes in favor of MNTA as things progress might exceed the value of Amphastar's market valuation. How would you asses the relative risk of each company? Is a single settlement from both companies a possibility? Is Watson still in business and was the time line such that they would have liability? (This possibility was raised by Dew). Thanks and regards, bp